Pacific Biosciences of California Inc (NASDAQ: PACB) is -26.23% lower on its value in year-to-date trading and has touched a low of $1.16 and a high of $5.23 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PACB stock was last observed hovering at around $1.32 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.35, the stock is -12.35% and -20.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.87 million and changing 2.66% at the moment leaves the stock -23.62% off its SMA200. PACB registered -75.59% loss for a year compared to 6-month gain of -0.74%.
The stock witnessed a -12.34% loss in the last 1 month and extending the period to 3 months gives it a -23.30%, and is -13.46% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.92% over the week and 13.01% over the month.
Pacific Biosciences of California Inc (PACB) has around 796 employees, a market worth around $369.72M and $154.01M in sales. Profit margin for the company is -200.40%. Distance from 52-week low is 16.38% and -74.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.15%).
with sales reaching $33.66M over the same period.The EPS is expected to grow by 33.82% this year, but quarterly earnings will post 5.07% year-over-year. Quarterly sales are estimated to shrink -13.26% in year-over-year returns.
Pacific Biosciences of California Inc (PACB) Top Institutional Holders
The shares outstanding are 273.86M, and float is at 243.51M with Short Float at 27.39%.
The top institutional shareholder in the company is ARK INVESTMENT MANAGEMENT LLC with over 33.21 million shares valued at $45.5 million. The investor’s holdings represent 12.1932% of the PACB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 26.0 million shares valued at $$35.62 million to account for 9.6443 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 23.61 million shares representing 8.7576% and valued at over $32.34 million, while MADRONE ADVISORS, LLC holds 8.5878 of the shares totaling 23.39 million with a market value of $32.05 million.
Pacific Biosciences of California Inc (PACB) Insider Activity
A total of 0 insider transactions have happened at Pacific Biosciences of California Inc (PACB) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Still, SEC filings show that on Feb 18 ’25, Farmer Michele disposed off 24,349 shares at an average price of $1.88 for $45727.0. The insider now directly holds 187,592 shares of Pacific Biosciences of California Inc (PACB).
Pacific Biosciences of California Inc (PACB): Who are the competitors?
The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -12.67% down over the past 12 months. Standard BioTools Inc. (LAB) that is -59.23% lower over the same period.
